Chief Executive Officer

As a single company, INC and inVentiv will offer end-to-end solutions to support drug development and commercialization. (Image: iStock/AndreyPopov)

INC Research, inVentiv merger 'a perfect fit'

By Melissa Fassbender

INC Research and inVentiv Health are merging to create one of the largest biopharmaceutical outsourcing providers – and a “top three CRO,” says CEO.

The acquisition is the latest in a series. (Image: iStock)

Charles River acquires analytical CRO

By Melissa Fassbender

Charles River Laboratories has acquired Blue Stream Laboratories, expanding the company’s biologic and biosimilar development capabilities.

Kaare Schultz resigned from Novo Nordisk today


Favourite for Novo Nordisk CEO suddenly quits

By Fiona BARRY

Kaare Schultz, Novo Nordisk Chief Operating Officer and planned successor as Chief Executive, resigned unexpectedly today. Plus FDA's ex-top scientist heads up US Pharmacopoeia.


Follow us


View more


Featured Suppliers

All suppliers